The drug delivery technology market is expected to reach USD 1,504.7 billion by 2020 from USD 1,048.1 billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. The market is categorized on the basis of route of administration, end user, and region. The route of administration market is further segmented into oral, pulmonary, ocular, nasal, topical, inject able, implantable and transmucosal drug delivery technology. The topical drug delivery technology market segment is expected to witness the highest CAGR in the forecast period.

Factors such as rising incidences of chronic diseases, growth of the biologics market, and innovation and technological advancements, are driving the growth of the drug delivery technology market. In addition, emphasis on innovation for improving the delivery of drugs is also contributing to the growth of the market. For instance, in February 2015, Sanofi and Mankind Corporation (U.S.) collaborated to launch Afrezza (insulin human) Inhalation Powder, inhalable insulin. This launch enabled the company to strengthen its product portfolio in nasal drug delivery. Such innovations are fueling the growth of the market.

Asia is expected to be the fastest-growing region in the drug delivery technology market. High growth in this market can be attributed to the increased population, rising prevalence of chronic diseases in the emerging markets, and existence of unmet medical needs.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the drug delivery technology market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market, share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the drug delivery technology market. The report analyzes this market by route of administration, end user, and geography
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the drug delivery technology market
• Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the drug delivery technology market
• Market Development: Comprehensive information about lucrative markets. The report analyzes the market for various drug delivery technology markets across countries
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the drug delivery technology market

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Market, By Topical Drug Delivery
4.2 Market, By End User
4.3 Solid Oral Drug Delivery Technology Market, By Dosage Form
4.4 Market, By Route of Administration
4.5 Geographic Snapshot of the Market

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 Market Segmentation, By Route of Administration
5.2.2 Market Segmentation, By End User
5.2.3 Market Segmentation, By Region
5.3 Market Dynamics
5.4 Drivers
5.4.1 Rising Prevalence of Chronic Diseases
5.4.2 Growth in the Biologics Market
5.4.3 New Product Launches
5.4.4 Drug Innovation and Technological Advancements
5.5 Restraints
5.5.1 Risk of Needle-Stick Injuries and Side Effects Related to Drugs
5.6 Opportunities
5.6.1 Self-Administration and Homecare Drug Delivery
5.6.2 Rising Demand for Biosimilars and Generic Drugs
5.6.2.1 Biosimilars
5.6.2.2 Generic Drugs
5.6.3 Collaborations Among Companies
5.6.4 Focus on Overcoming Unmet Medical Needs
5.6.5 Emerging Markets
5.7 Challenges
5.7.1 Product Recalls
5.7.2 Patent Expiry and Patent Cliff
5.7.3 Regulatory Hurdles and Pricing Pressure

6 Drug Delivery Technology Market, By Route of Administration
6.1 Introduction
6.2 Oral Drug Delivery
6.2.1 Solid Oral Drugs
6.2.1.1 Tablets
6.2.1.2 Capsules
6.2.1.3 Powders
6.2.1.4 Pills
6.2.2 Liquid Oral Drugs
6.2.2.1 Solutions
6.2.2.2 Syrups
6.2.3 Semi-Solid Oral Drugs
6.2.3.1 Gels
6.2.3.2 Emulsions
6.2.3.3 Elixirs
6.3 Pulmonary Drug Delivery
6.3.1 Metered Dose Inhalers
6.3.2 Dry Powder Inhalers
6.3.3 Nebulizers
6.3.3.1 Jet Nebulizers
6.3.3.2 Ultrasonic Nebulizers
6.3.3.3 Soft Mist Nebulizers
6.4 Injectable Drug Delivery
6.4.1 Injectable Drug Delivery Devices
6.4.1.1 Conventional Injectables
6.4.1.2 By Material
6.4.1.2.1 Glass
6.4.1.2.2 Plastic
6.4.1.3 By Product
6.4.1.3.1 Fillable Syringes
6.4.1.3.2 Prefilled Syringes
6.4.1.4 By Usability
6.4.1.4.1 Reusable Syringes
6.4.1.4.2 Disposable Syringes
6.4.1.5 Self-Injection Devices
6.4.1.6 Needle-Free Injectors
6.4.1.7 Autoinjectors
6.4.1.8 Pen Injectors
6.4.1.9 Wearable Injectors
6.4.1.10 Other Devices
6.4.2 Injectable Drug Delivery Formulations
6.4.2.1 Conventional Drug Delivery
6.4.2.2 Novel Drug Delivery Formulations
6.4.2.3 Long-Acting Injection Formulations
6.5 Ocular Drug Delivery
6.5.1 Liquid Ocular Drug Delivery
6.5.1.1 Eye Drops
6.5.1.2 Liquid Sprays
6.5.2 Semi-Solid Ocular Drug Delivery
6.5.2.1 Gels
6.5.2.2 Eye Ointments
6.5.3 Ocular Devices
6.5.3.1 Contact Lenses Coated With Drugs
6.5.3.2 Ocular Inserts
6.6 Nasal Drug Delivery
6.6.1 Nasal Drops
6.6.2 Nasal Sprays
6.6.3 Nasal Powders
6.6.4 Nasal Gels
6.7 Topical Drug Delivery
6.7.1 Liquid Topical Drug Delivery
6.7.1.1 Solutions
6.7.1.2 Suspensions
6.7.2 Semi-Solid Topical Drug Delivery
6.7.2.1 Creams
6.7.2.2 Gels
6.7.2.3 Ointments
6.7.2.4 Pastes
6.7.2.5 Lotions
6.7.3 Solid Topical Drug Delivery
6.7.3.1 Suppositories
6.7.3.2 Powders
6.7.4 Transdermal Drug Delivery
6.7.4.1 Transdermal Patches
6.7.4.2 Transdermal Gels
6.8 Implantable Drug Delivery
6.8.1 Active Implantable Drug Delivery
6.8.2 Passive Implantable Drug Delivery
6.9 Transmucosal Drug Delivery
6.9.1 Oral Transmucosal Drug Delivery
6.9.1.1 Buccal Drug Delivery
6.9.1.2 Sublingual Drug Delivery
6.9.2 Other Transmucosal Drug Delivery
6.9.2.1 Rectal Transmucosal Drug Delivery
6.9.2.2 Vaginal Transmucosal Drug Delivery

7 Drug Delivery Technology Market, By End User
7.1 Introduction
7.2 Hospitals
7.3 Home Care Settings
7.4 Ambulatory Surgical Centers/Clinics
7.5 Diagnostic Centers
7.6 Other End Users

8 Drug Delivery Technology Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.4 Asia
8.5 Rest of the World

9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis
9.3 Competitive Situations & Trends
9.3.1 New Product Launches & Approvals
9.3.2 Partnerships, Agreements, and Collaborations
9.3.3 Acquisitions
9.3.4 Expansions

10 Company Profiles
(Overview, Financials, Products & Services, Strategy, & Developments)*
10.1 Introduction
10.2 Bayer AG
10.3 Johnson & Johnson Services, Inc.
10.4 Novartis AG
10.5 Pfizer, Inc.
10.6 F. Hoffmann-La Roche Ltd.
10.7 3M Company
10.8 Antares Pharma, Inc.
10.9 Glaxosmithkline PLC
10.10 Merck & Co., Inc.
10.11 Sanofi

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

11 Appendix
11.1 Insights From Industry Experts
11.2 Discussion Guide
11.3 Other Developments, 2012–2015
11.4 Available Customizations
11.5 RT: Real-Time Market Intelligence
11.6 Related Reports

List of Tables

Table 1 List of Biologics Expected to Gain U.S. Regulatory Approval in 2015
Table 2 Major Product Launches in 2015
Table 3 Examples of Technological Advancements in Drug Delivery (2014–2015)
Table 4 Rising Prevalence of Chronic Diseases is Driving Market Growth
Table 5 Risk of Needle-Stick Injuries and Side Effects Related to Drugs are Restraining Market Growth
Table 6 Recent Collaborations in the Market, 2014–2015
Table 7 Emerging Markets Expected to Offer Significant Opportunities for Market Players
Table 8 Major Product Recalls in the Market, 2015
Table 9 Patent Expiry of Drugs, 2014–2015
Table 10 Product Recalls Pose A Significant Challenge for Market Growth
Table 11 Market Size, By Route of Administration, 2013–2020 (USD Billion)
Table 12 Market Size, By Region, 2013–2020 (USD Billion)
Table 13 Oral Drug Delivery Technologies Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 14 Oral Drug Delivery Technologies  Market Size, By Region, 2013–2020 (USD Billion)
Table 15 Oral Drug Delivery Technologies  Market Size for Solid Drugs, By Region, 2013–2020 (USD Billion)
Table 16 Solid Oral Drug Delivery Technologies Market Size for Tablets, By Region, 2013–2020 (USD Billion)
Table 17 Solid Oral Drug Delivery Technologies Market Size for Capsules, By Region, 2013–2020 (USD Billion)
Table 18 Solid Oral Drug Delivery Technologies Market Size for Powders, By Region, 2013–2020 (USD Billion)
Table 19 Solid Oral Drug Delivery Technologies Market Size for Pills, By Region, 2013–2020 (USD Billion)
Table 20 Liquid Oral Drug Delivery Technologies Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 21 Liquid Oral Drug Delivery Technologies Market Size, By Region, 2013–2020 (USD Billion)
Table 22 Liquid Oral Drug Delivery Technologies Market Size for Solutions, By Region, 2013–2020 (USD Billion)
Table 23 Liquid Oral Drug Delivery Technologies Market Size for Syrups, By Region, 2013–2020 (USD Billion)
Table 24 Semi-Solid Oral Drug Delivery Technologies Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 25 Semi-Solid Oral Drug Delivery Technologies Market Size, By Region, 2013–2020 (USD Billion)
Table 26 Semi-Solid Oral Drug Delivery Technologies Market Size for Gels, By Region, 2013–2020 (USD Billion)
Table 27 Semi-Solid Oral Drug Delivery Technologies Market Size for Emulsions, By Region, 2013–2020 (USD Billion)
Table 28 Semi-Solid Oral Drug Delivery Technologies Market Size for Elixirs, By Region, 2013–2020 (USD Billion)
Table 29 Pulmonary Drug Delivery Technologies Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 30 Pulmonary Drug Delivery Technologies Market Size, By Region, 2013–2020 (USD Billion)
Table 31 Pulmonary Drug Delivery Technologies Market Size for Metered Dose Inhalers, By Region, 2013–2020 (USD Billion)
Table 32 Pulmonary Drug Delivery Technology Market Size for Dry Powder Inhalers, By Region, 2013–2020 (USD Billion)
Table 33 Pulmonary Drug Delivery Technology Market Size for Nebulizers, By Dosage Form, 2013–2020 (USD Billion)
Table 34 Pulmonary Drug Delivery Technology Market Size for Nebulizers, By Region, 2013–2020 (USD Billion)
Table 35 Jet Nebulizers Market Size, By Region, 2013–2020 (USD Billion)
Table 36 Ultrasonic Nebulizers Market Size, By Region, 2013–2020 (USD Billion)
Table 37 Soft Mist Nebulizers Market Size, By Region, 2013–2020 (USD Billion)
Table 38 Injectable Drug Delivery Technology Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 39 Injectable Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 40 Injectable Drug Delivery Devices Market Size, By Type, 2013–2020 (USD Billion)
Table 41 Injectable Drug Delivery Devices Market Size, By Region, 2013–2020 (USD Billion)
Table 42 Injectable Drug Delivery Devices Market Size for Conventional Injectables, By Region, 2013–2020 (USD Billion)
Table 43 Injectable Drug Delivery Devices Market Size for Conventional Injectables, By Material, 2013–2020 (USD Billion)
Table 44 Conventional Glass Injection Devices Market Size, By Region, 2013–2020 (USD Billion)
Table 45 Conventional Plastic Injection Devices Market Size, By Region, 2013–2020 (USD Billion)
Table 46 Injectable Drug Delivery Devices Market Size for Conventional Injectables, By Product, 2013–2020 (USD Billion)
Table 47 Conventional Fillable Syringes Market Size, By Region, 2013–2020 (USD Billion)
Table 48 Conventional Prefilled Syringes Market Size, By Region, 2013–2020 (USD Billion)
Table 49 Injectable Drug Delivery Devices Market Size for Conventional Injectables, By Usability, 2013–2020 (USD Billion)
Table 50 Conventional Reusable Syringes Market Size, By Region, 2013–2020 (USD Billion)
Table 51 Conventional Disposable Syringes Market Size, By Region, 2013–2020 (USD Billion)
Table 52 Injectable Drug Delivery Devices Market Size for Self-Injection Devices, By Type, 2013–2020 (USD Billion)
Table 53 Injectable Drug Delivery Devices Market Size for Self-Injection Devices, By Region, 2013–2020 (USD Billion)
Table 54 Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Billion)
Table 55 Autoinjectors Market Size, By Region, 2013–2020 (USD Billion)
Table 56 Pen Injectors Market Size, By Region, 2013–2020 (USD Billion)
Table 57 Wearable Injectors Market Size, By Region, 2013–2020 (USD Billion)
Table 58 Other Devices Market Size, By Region, 2013–2020 (USD Billion)
Table 59 Injectable Drug Delivery Formulations Market Size, By Type, 2013–2020 (USD Billion)
Table 60 Injectable Drug Delivery Formulations Market Size, By Region, 2013–2020 (USD Billion)
Table 61 Conventional Drug Delivery Formulations Market Size, By Region, 2013–2020 (USD Billion)
Table 62 Novel Drug Delivery Formulations Market Size, By Region, 2013–2020 (USD Billion)
Table 63 Long-Acting Injection Formulations Market Size, By Region, 2013–2020 (USD Billion)
Table 64 Ocular Drug Delivery Technologies Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 65 Ocular Drug Delivery Technologies Market Size, By Region, 2013–2020 (USD Billion)
Table 66 Liquid Ocular Drug Delivery Technologies Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 67 Liquid Ocular Drug Delivery Technologies Market Size, By Region, 2013–2020 (USD Billion)
Table 68 Liquid Ocular Drug Delivery Technologies Market Size for Eye Drops, By Region, 2013–2020 (USD Billion)
Table 69 Liquid Ocular Drug Delivery Technologies Market Size for Liquid Sprays, By Region, 2013–2020 (USD Billion)
Table 70 Semi-Solid Ocular Drug Delivery Technologies Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 71 Semi-Solid Ocular Drug Delivery Technologies Market Size, By Region, 2013–2020 (USD Billion)
Table 72 Semi-Solid Ocular Drug Delivery Technology Market Size for Gels, By Region, 2013–2020 (USD Billion)
Table 73 Semi-Solid Ocular Drug Delivery Technologies Market Size for Eye Ointments, By Region, 2013–2020 (USD Billion)
Table 74 Ocular Devices Drug Delivery Technology Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 75 Ocular Devices Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 76 Contact Lens Coated With Drugs Market Size, By Region, 2013–2020 (USD Billion)
Table 77 Ocular Inserts Market Size, By Region, 2013–2020 (USD Billion)
Table 78 Nasal Drug Delivery Technologies Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 79 Nasal Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 80 Nasal Drops Market Size, By Region, 2013–2020 (USD Billion)
Table 81 Nasal Sprays Market Size, By Region, 2013–2020 (USD Billion)
Table 82 Nasal Powders Market Size, By Region, 2013–2020 (USD Billion)
Table 83 Nasal Gels Market Size, By Region, 2013–2020 (USD Billion)
Table 84 Topical Drug Delivery Technology Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 85 Topical Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 86 Liquid Topical Drug Delivery Technology Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 87 Liquid Topical Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 88 Topical Drug Delivery Solutions Market Size, By Region, 2013–2020 (USD Billion)
Table 89 Topical Drug Delivery Suspensions Market Size, By Region, 2013–2020 (USD Billion)
Table 90 Semi-Solid Topical Drug Delivery Technology Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 91 Semi-Solid Topical Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 92 Topical Drug Delivery Creams Market Size, By Region, 2013–2020 (USD Billion)
Table 93 Topical Drug Delivery Gels Market Size, By Region, 2013–2020 (USD Billion)
Table 94 Topical Drug Delivery Ointments Market Size, By Region, 2013–2020 (USD Billion)
Table 95 Topical Drug Delivery Pastes Market Size, By Region, 2013–2020 (USD Billion)
Table 96 Topical Drug Delivery Lotions Market Size, By Region, 2013–2020 (USD Billion)
Table 97 Solid Topical Drug Delivery Technology Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 98 Solid Topical Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 99 Topical Drug Delivery Suppositories Market Size, By Region, 2013–2020 (USD Billion)
Table 100 Topical Drug Delivery Powders Market Size, By Region, 2013–2020 (USD Billion)
Table 101 Transdermal Drug Delivery Technology Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 102 Transdermal Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 103 Transdermal Patches Market Size, By Region, 2013–2020 (USD Billion)
Table 104 Transdermal Gels Market Size, By Region, 2013–2020 (USD Billion)
Table 105 Implantable Drug Delivery Technology Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 106 Implantable Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 107 Active Implantable Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 108 Passive Implantable Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 109 Transmucosal Drug Delivery Technology Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 110 Transmucosal Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 111 Oral Transmucosal Drug Delivery Technology Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 112 Oral Transmucosal Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 113 Buccal Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 114 Sublingual Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 115 Other Transmucosal Drug Delivery Technology Market Size, By Dosage Form, 2013–2020 (USD Billion)
Table 116 Other Transmucosal Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 117 Rectal Transmucosal Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 118 Vaginal Transmucosal Drug Delivery Technology Market Size, By Region, 2013–2020 (USD Billion)
Table 119 Market Size, By End User, 2013–2020 (USD Billion)
Table 120 Market Size, By Region, 2013–2020 (USD Billion)
Table 121 Market Size for Hospitals, By Region, 2013–2020 (USD Billion)
Table 122 Market Size for Home Care Settings, By Region, 2013–2020 (USD Billion)
Table 123 Market Size for Ambulatory Surgical Centers/Clinics, By Region, 2013–2020 (USD Billion)
Table 124 Market Size for Diagnostic Centers, By Region, 2013–2020 (USD Billion)
Table 125 Market Size for Other End Users, By Region, 2013–2020 (USD Billion)
Table 126 Market Size, By Region, 2013-2020 (USD Billion)
Table 127 North America: Market Size, By Country, 2013-2020 (USD Billion)
Table 128 North America: Market Size, By Route of Administration, 2013–2020 (USD Billion)
Table 129 North America: Market Size, By End User, 2013–2020 (USD Billion)
Table 130 U.S.: Market Size, By Route of Administration, 2013–2020 (USD Billion)
Table 131 U.S.: Market Size, By End User, 2013–2020 (USD Billion)
Table 132 Canada: Market Size, By Route of Administration, 2013–2020 (USD Billion)
Table 133 Canada: Market Size, By End User, 2013–2020 (USD Billion)
Table 134 Europe: Market Size, By Route of Administration, 2013–2020 (USD Billion)
Table 135 Europe: Market Size, By End User, 2013–2020 (USD Billion)
Table 136 Asia: Market Size, By Route of Administration, 2013–2020 (USD Billion)
Table 137 Asia: Market Size, By End User, 2013–2020 (USD Billion)
Table 138 RoW: Market Size, By Route of Administration, 2013–2020 (USD Billion)
Table 139 RoW: Market Size, By End User, 2013–2020 (USD Billion)
Table 140 New Product Launches & Approvals, 2012–2015
Table 141 Partnerships, Agreements, and Collaborations, 2012–2015
Table 142 Acquisitions, 2012–2015
Table 143 Expansions, 2012–2015

List of Figures

Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Market, By Route of Administration (2015 vs 2020)
Figure 7 Oral Drug Delivery Technology Market, By Dosage Form, 2015 vs 2020
Figure 8 Hospitals Form the Largest End-User Segment
Figure 9 Topical Drug Delivery Technology Market, By Dosage Form, 2015 vs 2020
Figure 10 Topical Drug Delivery Segment to Grow at the Highest CAGR From 2015 to 2020
Figure 11 Hospitals Segment to Dominate Market in the Forecast Period
Figure 12 Tablets Segment to Account for the Largest Share in 2015
Figure 13 Injectable Drug Delivery Technology to Offer Significant Contribution to the Overall Market Growth (2015-2020)
Figure 14 Asia to Witness Highest Growth During the Forecast Period
Figure 15 Market Segmentation, By Route of Administration
Figure 16 Market Segmentation, By End User
Figure 17 Market Segmentation, By Region
Figure 18 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Topical Drug Delivery to Witness Highest Growth in the Forecast Period
Figure 20 Solid Oral Drug Delivery to Witness Highest Growth in the Forecast Period
Figure 21 Nebulizers to Witness Highest Growth in the Forecast Period
Figure 22 Formulations to Witness Highest Growth in the Forecast Period
Figure 23 Liquid Ocular Drug Delivery to Witness Highest Growth in the Forecast Period
Figure 24 Nasal Sprays to Witness Highest Growth in the Forecast Period
Figure 25 Semi-Solid Topical Drug Delivery to Witness Highest Growth in the Forecast Period
Figure 26 Passive Implantable Drug Delivery to Witness Highest Growth in the Forecast Period
Figure 27 Oral Transmucosal Drug Delivery to Witness Highest Growth in the Forecast Period
Figure 28 Market Segmentation, By End User
Figure 29 Market, By End User: Hospitals to Hold Largest Market Share in 2015
Figure 30 North America to Hold the Largest Share of the Global Market (2015)
Figure 31 European Market Snapshot (2015)
Figure 32 Asia to Be the Fastest-Growing Regional Segment of the Global Market (2015)
Figure 33 Rising Prevalence of Chronic Diseases to Drive the Growth of the Market in the RoW (2015)
Figure 34 New Product Launches & Approvals is the Key Growth Strategy Adopted By Players in the Drug Delivery Market During the Studied Period (2014-2015)
Figure 35 Global Market Share, By Key Player (2014)
Figure 36 Market Evolution Framework: New Product Launches & Approvals are Fueling Market Growth
Figure 37 Battle for Market Share: New Product Launches & Approvals is the Key Growth Strategy Adopted By Leading Players in 2015
Figure 38 Geographic Revenue Mix for the Top 5 Players
Figure 39 Bayer AG: Company Snapshot
Figure 40 Johnson & Johnson Services, Inc.: Company Snapshot
Figure 41 Novartis AG: Company Snapshot
Figure 42 Pfizer, Inc.: Company Snapshot
Figure 43 F. Hoffmann-La Roche Ltd.: Company Snapshot
Figure 44 3M Company: Company Snapshot
Figure 45 Antares Pharma, Inc: Company Snapshot
Figure 46 Glaxosmithkline PLC: Company Snapshot
Figure 47 Merck & Co., Inc.: Company Snapshot
Figure 48 Sanofi: Company Snapshot